Skip to main content
. 2016 Oct;10(4):542–547.

Table 1.

The chemotherapy protocols follow up schedule and cancer site of experimental patients

Group Sample size Chemotherapy protocol Patient neoplasm type Chemotherapy schedule (days) Follow up schedule (days)
G-I 45 Vinorelbine Metastatic breast cancer 1, 7, 14, 21 6, 13, 20, 28
NSCL Cancer 1, 7, 14, 21 6, 13, 20, 28
G-II 15 Vinorelbine/Doxurubicin Metastatic breast cancer 1, 8 7, 15
Vinorelbine/Cisplatin NSCL Cancer 1, 8 7, 15
Cervix Cancer 1, 8 7, 15